|By PR Newswire||
|February 21, 2014 01:00 PM EST||
DUBLIN, Ireland, February 21, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/gcm8p2/life_sciences_bpo) has announced the addition of the "Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering.
Economic burden, increased financial crisis and technological advances has compelled all pharmaceutical, biotechnology and life science companies to outsource their R&D activities and manufacturing processes in order to achieve their cost benefits and save time.In recent years, large number of life science companies has modified their traditional drug manufacturing operations with more focus now on their core R&D activities and manufacturing processes via outsourcing. At present, new outsourcing strategies and types of services are developing in almost every stage of research and manufacturing process. For instance, a virtually integrated, cross-functional outsourcing of drug discovery research is currently being considered as a latest outsourcing model, especially for small molecule drug discovery. In addition, genomics & proteomics research and gene-silencing technology are now being widely used for target identification and validation of complex disease targets.
Global Life Sciences BPO market includes Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and others that compriseContract Sales Organization (CSO). The contract manufacturing organizations market is expected to see the highest growth rate during the forecast period and also accounted for the largest market share in the year 2012. This market holds immense growth owing to the rise in demand for generic drugs, increase in R&D investment by life sciences companies. In addition, a rise in the number of block buster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market.
The CMO market comprises contract API (Active Pharmaceutical Ingredients) manufacturing, contract FDF (Finished Dosage Formulations) manufacturing and packaging.Among these, contract FDF manufacturing segment is expected to have a healthy growth rate during the forecast period. The CRO market is also expected to display a healthy growth rate after CMO market. The CRO market comprises of various segments such as drug discovery, pre-clinical studies, clinical trial phases, medical writing, clinical data management, pharmacovigilance, regulatory services, site management, protocol development, monitoring and bio-statistics. Among these, clinical data management segment is expected to have a strong growth rate in coming years. This growth has been attributed to its high data complexities, high cost involvement and requirement of skilled & trained professionals.
Key Topics Covered:
2 Executive Summary
3 Global Life Sciences BPO Market Dynamics
4 Global Life Sciences BPO Market, by Segments
5 Global Life Sciences BPO Market, by Geography
6 Global Life Sciences BPO Market Share Analysis
8 Company Profiles
9 List of the Companies
- Accenture, Plc
- Boehringer Ingelheim GmbH
- Catalent Pharma Solutions, Inc.
- Charles River Laboratories International, Inc. (CRL)
- Cognizant Technology Solutions
- Covance, Inc.
- ICON, Plc
- International Business Machines Corporation
- Lonza Group
- Pharmaceutical Product Development, Inc. (PPD, Inc.)
- Parexel International Corporation
- Patheon, Inc.
- Piramal Healthcare
- PRA International, Inc.
- Quintiles Transnational Corporation
- Wipro Limited
For more information visit http://www.researchandmarkets.com/research/gcm8p2/life_sciences_bpo
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
In their session at 17th Cloud Expo, Hal Schwartz, CEO of Secure Infrastructure & Services (SIAS), and Chuck Paolillo, CTO of Secure Infrastructure & Services (SIAS), provide a study of cloud adoption trends and the power and flexibility of IBM Power and Pureflex cloud solutions. In his role as CEO of Secure Infrastructure & Services (SIAS), Hal Schwartz provides leadership and direction for the company.
Aug. 4, 2015 06:45 PM EDT Reads: 224
There are many considerations when moving applications from on-premise to cloud. It is critical to understand the benefits and also challenges of this migration. A successful migration will result in lower Total Cost of Ownership, yet offer the same or higher level of robustness. In his session at 15th Cloud Expo, Michael Meiner, an Engineering Director at Oracle, Corporation, analyzed a range of cloud offerings (IaaS, PaaS, SaaS) and discussed the benefits/challenges of migrating to each offe...
Aug. 4, 2015 06:45 PM EDT Reads: 208
Aug. 4, 2015 05:30 PM EDT
Aug. 4, 2015 05:00 PM EDT Reads: 107
Aug. 4, 2015 03:00 PM EDT Reads: 573
Aug. 4, 2015 02:45 PM EDT
Aug. 4, 2015 02:00 PM EDT Reads: 385
Aug. 4, 2015 01:30 PM EDT
Aug. 4, 2015 01:00 PM EDT Reads: 291
Aug. 4, 2015 12:00 PM EDT Reads: 113
Aug. 4, 2015 11:45 AM EDT
Aug. 4, 2015 11:30 AM EDT Reads: 115
Aug. 4, 2015 09:30 AM EDT Reads: 112
Aug. 4, 2015 08:45 AM EDT Reads: 259
Aug. 4, 2015 07:00 AM EDT Reads: 226